ZM-216800

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameZM-216800
Drug Alias NameZM-216800
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionArachidonate 5-lipoxygenase inhibitors
TargetsArachidonate 5-lipoxygenase
Therapy Area/IndicationsAsthmaArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZeneca Group Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZeneca Group Plc
Active IndicationsN/A
Inactive IndicationsAsthmaArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A